NCT03673124 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 49
- units
- Participants
- groups
- description
- Ribociclib 600 mg administered orally daily for 21 days followed by 7 days off in 28-day treatment cycle in combination with Letrozole 2.5 mg administered orally daily for 28 days. Treatment continues until disease progression or unacceptable toxicity.
- id
- BG000
- title
- Ribociclib and Letrozole
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 4
- title
- 20-29
- measurements
- group Id
- BG000
- value
- 6
- title
- 30-39
- measurements
- group Id
- BG000
- value
- 7
- title
- 40-49
- measurements
- group Id
- BG000
- value
- 8
- title
- 50-59
- measurements
- group Id
- BG000
- value
- 17
- title
- 60-69
- measurements
- group Id
- BG000
- value
- 6
- title
- 70-79
- measurements
- group Id
- BG000
- value
- 1
- title
- 80-89
- title
- Age (Years)
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 49
- title
- Female
- measurements
- group Id
- BG000
- value
- 0
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- Black
- measurements
- group Id
- BG000
- value
- 44
- title
- White
- measurements
- group Id
- BG000
- value
- 1
- title
- Unknown
- measurements
- group Id
- BG000
- value
- 1
- title
- Declined to Report
- title
- Race
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 9
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 38
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 1
- title
- Declined to Report
- measurements
- group Id
- BG000
- value
- 1
- title
- Unknown
- title
- Ethnicity
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 49
- title
- United States
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Region of Enrollment
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 27
- title
- ECOG 0
- measurements
- group Id
- BG000
- value
- 21
- title
- ECOG 1
- measurements
- group Id
- BG000
- value
- 1
- title
- Not Reported
- description
- ECOG 0 is fully active, able to carry on all pre-disease performance without restriction. ECOG 1 is restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Performance Status (ECOG)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 44
- title
- Ovary
- measurements
- group Id
- BG000
- value
- 5
- title
- Peritoneum
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Site of Disease
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- I
- measurements
- group Id
- BG000
- value
- 1
- title
- II
- measurements
- group Id
- BG000
- value
- 36
- title
- III
- measurements
- group Id
- BG000
- value
- 9
- title
- IV
- measurements
- group Id
- BG000
- value
- 1
- title
- Not Reported
- description
- FIGO stage at diagnosis was reported by each participant institution according to their standard practice. In general, a higher FIGO stage indicates more advanced disease.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- FIGO Stage at Diagnosis (ohr)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- No
- measurements
- group Id
- BG000
- value
- 46
- title
- Yes
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Prior Surgery
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 48
- title
- No
- measurements
- group Id
- BG000
- value
- 1
- title
- Yes
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Prior Radiation Therapy (ohr)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- No
- measurements
- group Id
- BG000
- value
- 46
- title
- Yes
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Any Prior Immunologic/Chemo/Hormonal/Biologic/Antiangiogenic/Other therapy
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- 0
- measurements
- group Id
- BG000
- value
- 20
- title
- 1
- measurements
- group Id
- BG000
- value
- 7
- title
- 2
- measurements
- group Id
- BG000
- value
- 6
- title
- 3
- measurements
- group Id
- BG000
- value
- 7
- title
- 4
- measurements
- group Id
- BG000
- value
- 1
- title
- 5
- measurements
- group Id
- BG000
- value
- 5
- title
- 6 or more
- description
- Any immunologic/chemo/hormonal/biologic/antiangiogenic/other therapy reported by participation sites, where a line of therapy was defined by the participation sites' standards.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Lines of Prior Therapy (ohr)
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 49
- units
- Participants
- groups
- description
- Ribociclib 600 mg administered orally daily for 21 days followed by 7 days off in 28-day treatment cycle in combination with Letrozole 2.5 mg administered orally daily for 28 days. Treatment continues until disease progression or unacceptable toxicity.
- id
- BG000
- title
- Ribociclib and Letrozole
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 4
- title
- 20-29
- measurements
- group Id
- BG000
- value
- 6
- title
- 30-39
- measurements
- group Id
- BG000
- value
- 7
- title
- 40-49
- measurements
- group Id
- BG000
- value
- 8
- title
- 50-59
- measurements
- group Id
- BG000
- value
- 17
- title
- 60-69
- measurements
- group Id
- BG000
- value
- 6
- title
- 70-79
- measurements
- group Id
- BG000
- value
- 1
- title
- 80-89
- title
- Age (Years)
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 49
- title
- Female
- measurements
- group Id
- BG000
- value
- 0
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- Black
- measurements
- group Id
- BG000
- value
- 44
- title
- White
- measurements
- group Id
- BG000
- value
- 1
- title
- Unknown
- measurements
- group Id
- BG000
- value
- 1
- title
- Declined to Report
- title
- Race
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 9
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 38
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 1
- title
- Declined to Report
- measurements
- group Id
- BG000
- value
- 1
- title
- Unknown
- title
- Ethnicity
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 49
- title
- United States
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Region of Enrollment
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 27
- title
- ECOG 0
- measurements
- group Id
- BG000
- value
- 21
- title
- ECOG 1
- measurements
- group Id
- BG000
- value
- 1
- title
- Not Reported
- description
- ECOG 0 is fully active, able to carry on all pre-disease performance without restriction. ECOG 1 is restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Performance Status (ECOG)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 44
- title
- Ovary
- measurements
- group Id
- BG000
- value
- 5
- title
- Peritoneum
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Site of Disease
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- I
- measurements
- group Id
- BG000
- value
- 1
- title
- II
- measurements
- group Id
- BG000
- value
- 36
- title
- III
- measurements
- group Id
- BG000
- value
- 9
- title
- IV
- measurements
- group Id
- BG000
- value
- 1
- title
- Not Reported
- description
- FIGO stage at diagnosis was reported by each participant institution according to their standard practice. In general, a higher FIGO stage indicates more advanced disease.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- FIGO Stage at Diagnosis (ohr)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- No
- measurements
- group Id
- BG000
- value
- 46
- title
- Yes
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Prior Surgery
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 48
- title
- No
- measurements
- group Id
- BG000
- value
- 1
- title
- Yes
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Prior Radiation Therapy (ohr)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- No
- measurements
- group Id
- BG000
- value
- 46
- title
- Yes
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Any Prior Immunologic/Chemo/Hormonal/Biologic/Antiangiogenic/Other therapy
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- 0
- measurements
- group Id
- BG000
- value
- 20
- title
- 1
- measurements
- group Id
- BG000
- value
- 7
- title
- 2
- measurements
- group Id
- BG000
- value
- 6
- title
- 3
- measurements
- group Id
- BG000
- value
- 7
- title
- 4
- measurements
- group Id
- BG000
- value
- 1
- title
- 5
- measurements
- group Id
- BG000
- value
- 5
- title
- 6 or more
- description
- Any immunologic/chemo/hormonal/biologic/antiangiogenic/other therapy reported by participation sites, where a line of therapy was defined by the participation sites' standards.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Lines of Prior Therapy (ohr)
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle